相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2013)
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R. Burmester et al.
LANCET (2013)
MECHANISMS OF DISEASE JAKs and STATs in Immunity, Immunodeficiency, and Cancer
John J. O'Shea et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Erythroid Disturbances Before and After Treatment of Portuguese Psoriasis Vulgaris Patients A Cross-Sectional and Longitudinal Study
Susana Coimbra et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
Leonid Gibiansky et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
IL-6 plays an essential role in neutrophilia under inflammation
Misato Hashizume et al.
CYTOKINE (2011)
Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
Andrew M. Lin et al.
JOURNAL OF IMMUNOLOGY (2011)
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Kamran Ghoreschi et al.
JOURNAL OF IMMUNOLOGY (2011)
Interleukin-5 and IL-5 receptor in health and diseases
Kiyoshi Takatsu
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2011)
Selective Functional Inhibition of JAK-3 Is Sufficient for Efficacy in Collagen-Induced Arthritis in Mice
Tsung H. Lin et al.
ARTHRITIS AND RHEUMATISM (2010)
Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
Debra M. Meyer et al.
JOURNAL OF INFLAMMATION-LONDON (2010)
New Insights in the Immunologic Basis of Psoriasis
Kristine E. Nograles et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2010)
Quantitative Analysis of Mechanisms That Govern Red Blood Cell Age Structure and Dynamics during Anaemia
Nicholas J. Savill et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia
Elizabeth Kudlacz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease
Lynda A. O'Sullivan et al.
MOLECULAR IMMUNOLOGY (2007)
Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats
Sukyung Woo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Targeting the Jak/STAT pathway for immunosuppression
JJ O'Shea
ANNALS OF THE RHEUMATIC DISEASES (2004)
Regulation of JAK-STAT signalling in the immune system
K Shuai et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Poriasis Associations - Data from the Nordic Quality of Life Study
H Zachariae et al.
ACTA DERMATO-VENEREOLOGICA (2002)
Intracellular signal transduction in eosinophils and its clinical significance
CK Wong et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2002)
Interleukin 9 promotes influx and local maturation of eosinophils
J Louahed et al.
BLOOD (2001)
Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: A neutrophil-associated inflammation-boosting loop
T Terui et al.
EXPERIMENTAL DERMATOLOGY (2000)
分享论文
